MET and lung carcinoma: Therefore, the antiproliferative effects of the compounds were tested against different lung cancer and PDAC cell lines by SRB assay, and it was observed that derivatives 6d, 6e and 6f with the highest c-Met inhibitory potential also suppressed the proliferation of cancer cells.